Twist Bioscience Corp. (TWST)
70.04
+0.82
(+1.18%)
USD |
NASDAQ |
Jun 08, 16:00
71.13
+1.09
(+1.56%)
Pre-Market: 08:36
Twist Bioscience Profit Margin (Quarterly) : -39.76% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | -297.2% |
| Intellia Therapeutics, Inc. | -639.5% |
| Sarepta Therapeutics, Inc. | 45.29% |
| Arrowhead Pharmaceuticals, Inc. | -186.6% |
| Oncolytics Biotech, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -17.65% |
| Return on Assets | -12.72% |
| Return on Invested Capital | -14.88% |
| Gross Profit Margin (Quarterly) | 51.59% |
| Operating Margin (Quarterly) | -34.92% |
| Return on Net Operating Assets | -23.81% |